Use of Electrotherapy

William Bloat is a 53 year old man with a BMI of 30 years who was classified as obese (WHO, 2014) and diagnosed with type 2 diabetes. William is living a sedentary life, working as a crane driver. The patient's greatest therapeutic purpose is a small wound on the foot. Due to decreased collagen synthesis and deposition, decreased wound break strength, and wound repair disorders characterized by leukocyte dysfunction, delayed cure may be associated with his diabetes (Kaviani et al, 2011 , Houreld and Abrahamse, 2010).

Currently, many medical devices use electrotherapy to treat chronic pain. Some popular types of electrotherapy used in these devices are TENS, PENS, EMS, IFC, PEMF and GS. The US Food and Drug Administration (FDA) has approved that these devices using electrotherapy are safe. Many of these devices are portable and can be easily used at home. The electrotherapy device is battery powered and has a conductive electrode pad. These pads are made of glue that helps them stick to the skin. When you turn on the device, a light electric pulse is sent to the skin, and when the nerve is operated by an electric pulse, it has a sense of irritation. These electrical signals help relieve pain or alleviate the pain. However, pregnant women and people suffering from heart disease never recommend using electrotherapy.

Note: The studies included in this review do not report large adverse effects of electrotherapy. Electrical therapy is prohibited for people wearing electrical implants (eg pacemakers) or pregnant. Electrotherapy is prohibited in the local anatomical region of the eye, testis and malignant tumors. Note: Negative pressure wound treatment for inappropriate debridement, necrosis or malignant wounds is not recommended; if significant organs are exposed; exudate free wounds or untreated coagulopathies, osteomyelitis, or local or Individuals with systemic clinical infections. For patients undergoing anticoagulant therapy, we recommend that you use cautious use by experienced medical professionals, active bleeding, or wounds close to the main vessel.

Treatment options currently under investigation for unidentified efficacy include hyperbaric oxygen therapy, electrotherapy, growth factors and negative pressure wound therapy (NPWT). Preliminary studies of electrotherapy seem promising and topical application of recombinant human growth factor becapplem is approved for use in patients with lower limb diabetic neuropathic ulcers. However, there is not enough evidence to recommend these treatments for the treatment of stress injuries.